Mumbai, July 14: A Pune-based firm today launched a vaccine for swine flu and said a similar drug for children below three years is likely to hit the market soon.
‘Nasovac’ is a indigenously developed intra-nasal vaccine for swine flu, a pandemic that has claimed over 1,000 lives in the country since its outbreak in May last year, Serum Institute of India Ltd Executive Director (Operations) Adar C Poonawalla told reporters here.
Serum is also in the process of developing an anti-swine flu vaccine for children below three years, he said, adding, “it is expected to hit the market in the next 2-3 months.”
The current vaccine, priced at Rs 160 per dose, is for adults and children above three years.
However, Nasovac is not to be administered to pregnant and lactating women.
–Agencies